OAS2 and acute myeloid leukemia: Interestingly, transcriptome profiling also revealed that a mRNA 2ʹ-5ʹ-oligoadenylate synthetase 2 (OAS2) was highly expressed and correlated with SATB1-AS1 expression in AML patients.